Results 171 to 180 of about 14,342,235 (381)

Improved Super-Resolution Ultrasound Microvessel Imaging With Spatiotemporal Nonlocal Means Filtering and Bipartite Graph-Based Microbubble Tracking

open access: green, 2017
Pengfei Song   +6 more
openalex   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

3D imaging of Sox2 enhancer clusters in embryonic stem cells

open access: gold, 2014
Zhe Liu   +7 more
openalex   +2 more sources

Images [PDF]

open access: yesCanadian Journal of Anaesthesia, 1992
openaire   +2 more sources

Imaging [PDF]

open access: yesStroke, 2005
Jean-Claude, Baron, Steven, Warach
openaire   +2 more sources

Sparse MRI: The application of compressed sensing for rapid MR imaging

open access: yesMagnetic Resonance in Medicine, 2007
M. Lustig, D. Donoho, J. Pauly
semanticscholar   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Quantitative 3D Analysis of Plant Roots Growing in Soil Using Magnetic Resonance Imaging

open access: green, 2016
Dagmar van Dusschoten   +7 more
openalex   +2 more sources

Images.

open access: yesCroatian medical journal, 2002
My medical experience from the Homeland War.
openaire   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy